908 Devices (MASS) Revenue Growth (3y) (2023 - 2026)
908 Devices (MASS) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 0.73% |
| 10 | 908 Devices | 260.31 Mn | 148.57 Mn | 6.88 Mn | 12.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.15% |
| Dec 31, 2025 | 14.29% |
| Sep 30, 2025 | -3.93% |
| Jun 30, 2025 | 5.48% |
| Mar 31, 2025 | 12.34% |
| Dec 31, 2024 | -3.26% |
| Sep 30, 2024 | 4.99% |
| Jun 30, 2024 | 11.46% |
| Mar 31, 2024 | 10.22% |
| Dec 31, 2023 | 35.91% |
| Sep 30, 2023 | 33.21% |
| Jun 30, 2023 | 2.81% |
| Mar 31, 2023 | 33.35% |